seborrhoea

(redirected from seborrhoeic)
Also found in: Medical.

seb·or·rhoe·a

 (sĕb′ə-rē′ə)
n. Chiefly British
Variant of seborrhea.

seb′or·rhoe′ic adj.

seborrhoea

(ˌsɛbəˈrɪə) or

seborrhea

n
(Pathology) any disease of the skin characterized by excessive secretion of sebum by the sebaceous glands and its accumulation on the skin surface
ˌseborˈrhoeal, ˌseborˈrhoeic ˌseborˈrheal, ˌseborˈrheic adj
Translations

seborrhoea

[ˌsebəˈrɪə] Nseborrea f

seborrhoea

, (US) seborrhea
nSeborrhö(e) f
References in periodicals archive ?
Symptoms: Red areas on the face, scalp and centre of the chest with greasy looking skin flakes often in the hairline, eyebrows and sides of nose Diagnosis: Seborrhoeic dermatitis Cause: An overgrowth of yeast called malassezia that lives on the skin, or an overreaction by the skin's immune system to this yeast.
Seborrhoeic dermatitis affects about 4% of the population, and dandruff - which is mild seborrhoeic dermatitis of the scalp - affects almost half of all adults at some point in their lives," says Dr Perry.
A dose-response study of irritant reactions to sodium lauryl sulphate in patients with seborrhoeic eczema and atopic eczema.
9%) patients had other diseases among whom, pre-existing itchy skin diseases like photodermatoses, chronic folliculitis, subacute eczema, lichen simplex chronicus, seborrhoeic dermatitis and recurrent pyoderma were present in 10 (26.
Clearance of seborrhoeic keratoses with topical dobesilate.
An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
Phospholipase activity after B-endorphin exposure discriminates Malassezia strains isolated from healthy and seborrhoeic dermatitis skin.
Hypersecretory--release of large volumes of oil and occurs in 100% of cases of seborrhoeic dermatitis and can also occur in acne rosacea
9 Acne vulgaris happens primarily in the seborrhoeic areas, such as the face, neck, chest or back.
1 EH has been diagnosed in some pre-existing inflammatory skin diseases such as atopic dermatitis, Hailey-Hailey disease, psoriasis, eczema, contact dermatitis, seborrhoeic dermatitis, and in patients with burns.
Recently, new cases of cutaneous eruptions induced by ponatinib have been reported, which include two cases of pythriasis rubra pilaris-like eruption, a folliculocentric form, a seborrhoeic form, an ichthyosiform eruption, and neutrophilic panniculitis (3-5).
In South Africa, there have been no studies conducted on patients with seborrhoeic dermatitis (SD).